SE0402268L - Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barn - Google Patents

Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barn

Info

Publication number
SE0402268L
SE0402268L SE0402268A SE0402268A SE0402268L SE 0402268 L SE0402268 L SE 0402268L SE 0402268 A SE0402268 A SE 0402268A SE 0402268 A SE0402268 A SE 0402268A SE 0402268 L SE0402268 L SE 0402268L
Authority
SE
Sweden
Prior art keywords
hhv
allergies
development
protection against
virus type
Prior art date
Application number
SE0402268A
Other languages
English (en)
Other versions
SE0402268D0 (sv
SE528319C2 (sv
Inventor
Inger Nordstroem
Kristina Eriksson
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0402268A priority Critical patent/SE528319C2/sv
Publication of SE0402268D0 publication Critical patent/SE0402268D0/sv
Priority to CA002580717A priority patent/CA2580717A1/en
Priority to EP05784509A priority patent/EP1796699A1/en
Priority to PCT/SE2005/001357 priority patent/WO2006031195A1/en
Publication of SE0402268L publication Critical patent/SE0402268L/sv
Publication of SE528319C2 publication Critical patent/SE528319C2/sv
Priority to US11/687,853 priority patent/US20070207169A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/763Herpes virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16511Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16533Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE0402268A 2004-09-17 2004-09-17 Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn SE528319C2 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0402268A SE528319C2 (sv) 2004-09-17 2004-09-17 Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn
CA002580717A CA2580717A1 (en) 2004-09-17 2005-09-16 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children.
EP05784509A EP1796699A1 (en) 2004-09-17 2005-09-16 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children.
PCT/SE2005/001357 WO2006031195A1 (en) 2004-09-17 2005-09-16 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children.
US11/687,853 US20070207169A1 (en) 2004-09-17 2007-03-19 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402268A SE528319C2 (sv) 2004-09-17 2004-09-17 Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn

Publications (3)

Publication Number Publication Date
SE0402268D0 SE0402268D0 (sv) 2004-09-17
SE0402268L true SE0402268L (sv) 2006-03-18
SE528319C2 SE528319C2 (sv) 2006-10-17

Family

ID=33308780

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402268A SE528319C2 (sv) 2004-09-17 2004-09-17 Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn

Country Status (5)

Country Link
US (1) US20070207169A1 (sv)
EP (1) EP1796699A1 (sv)
CA (1) CA2580717A1 (sv)
SE (1) SE528319C2 (sv)
WO (1) WO2006031195A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20075063A0 (sv) 2007-02-01 2007-02-01 Vactech Oy Prevention av allergisk sensibilisering

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524421B1 (en) * 1991-07-08 2003-03-26 Dade Behring Marburg GmbH Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
US5716623A (en) * 1994-12-07 1998-02-10 Immunex Corporation Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules
EP1383536B1 (en) * 2001-03-28 2012-08-08 THE GOVERNMENT OF THE UNITED STATES, As represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Use of herpesviruses to inhibit ccr5-tropic hiv-1 infection and replication

Also Published As

Publication number Publication date
CA2580717A1 (en) 2006-03-23
SE0402268D0 (sv) 2004-09-17
EP1796699A1 (en) 2007-06-20
US20070207169A1 (en) 2007-09-06
SE528319C2 (sv) 2006-10-17
WO2006031195A1 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
CY2018025I2 (el) Εμβολιο ιου ερπητα ζωστηρα
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
NO20033272L (no) Et virus som forårsaker sykdom i luftveiene i mottakelige pattedyr
DE602005025438D1 (de) Staubsauger mit Zyklon-Filter
NO20085420L (no) Farmasøytisk formulering med fenylefrin og preparater for absorpsjon i tykktarmen
ATE472534T1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
FR2885139B1 (fr) Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales
DE60304993D1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
FR2863607B1 (fr) Vitroceramiques a surface modifiee et leur preparation
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
EP1765330A4 (en) PYRANOINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DISEASE OR INFECTION CAUSED BY HEPATITIS C VIRUS
DK1694694T3 (da) Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
FR2823222B1 (fr) Vaccin contre le virus de la fievre du nil
EP1552021A4 (en) INTERFERON TYPE I INDUCIBLE PROTEINS FOR THE DETECTION OF VIRUS INFECTION
SE0402268L (sv) Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barn
SE0601947L (sv) Lagringsstabila polymer-oligomer-partiklar och deras användning vid svällningspolymerisation
DK1973931T3 (da) Hønsevirusvaccine og -diagnosticering
DE602006010337D1 (de) 1,2,4-triazinderivate, ihre herstellung und ihre verwendung in der humantherapie
AU2003243663A8 (en) Vaccines for suppressing ige-mediated allergic disease and methods for using the same
DE602004020063D1 (de) Pyrido[2,3-d] pyrimidin-7-carbonsäurederivate, deren herstellung und deren verwendung als pharmazeutische mittel
DE602006008971D1 (de) N-ä(4,5-diphenylpyrimidin-2-yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung
DK1945797T3 (da) Hepatitis C-virus NS2/3-aktivitetsanalyse
DE602005001505D1 (de) Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel
DE602005005033D1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
NUG Patent has lapsed